APA (7th ed.) Citation

Hose, D., Rème, T., Hielscher, T., Moreaux, J., Messner, T., Seckinger, A., . . . Goldschmidt, H. (2011). Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma. Haematologica, the hematology journal, 96(1), . https://doi.org/10.3324/haematol.2010.030296

Chicago Style (17th ed.) Citation

Hose, Dirk, et al. "Proliferation Is a Central Independent Prognostic Factor and Target for Personalized and Risk-adapted Treatment in Multiple Myeloma." Haematologica, the Hematology Journal 96, no. 1 (2011). https://doi.org/10.3324/haematol.2010.030296.

MLA (9th ed.) Citation

Hose, Dirk, et al. "Proliferation Is a Central Independent Prognostic Factor and Target for Personalized and Risk-adapted Treatment in Multiple Myeloma." Haematologica, the Hematology Journal, vol. 96, no. 1, 2011, https://doi.org/10.3324/haematol.2010.030296.